Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

A nurse has revealed exactly what you need to be drinking when you're on a GLP-1 medication - and why hydration on the ...

Love Is Blind' alum Chelsea Blackwell shares her weight loss transformation after beginning the use of an injectable medication, despite facing criticism for doing so.

The state’s second-largest insurer is grappling with heightened health care spending and a market that is increasingly unable ...

The prevalence of U.S. adults without diabetes who filled a GLP-1 receptor agonist prescription rose from 0.1% in 2018 to 0.4 ...

The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired with shortages has created a market for counterfeits.

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

GLP-1 medications are reshaping the weight management landscape — and beginning to take a bite out of bariatric surgery volumes in hospitals. Between 2022 and 2023, bariatric surgery rates fell 25.6% ...

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching emerging channels and artificial ...